AP2001002354A0 - Use of antibodies recognizing the interleukin-2 receptor in the prevention and /or treatment of infections by the AIDS viruses. - Google Patents

Use of antibodies recognizing the interleukin-2 receptor in the prevention and /or treatment of infections by the AIDS viruses.

Info

Publication number
AP2001002354A0
AP2001002354A0 APAP/P/2001/002354A AP2001002354A AP2001002354A0 AP 2001002354 A0 AP2001002354 A0 AP 2001002354A0 AP 2001002354 A AP2001002354 A AP 2001002354A AP 2001002354 A0 AP2001002354 A0 AP 2001002354A0
Authority
AP
ARIPO
Prior art keywords
interleukin
receptor
infections
prevention
treatment
Prior art date
Application number
APAP/P/2001/002354A
Other languages
English (en)
Inventor
Pierre- Francois Serres
Original Assignee
Hippocampe
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hippocampe filed Critical Hippocampe
Publication of AP2001002354A0 publication Critical patent/AP2001002354A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
APAP/P/2001/002354A 1999-05-21 2000-05-22 Use of antibodies recognizing the interleukin-2 receptor in the prevention and /or treatment of infections by the AIDS viruses. AP2001002354A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9906528A FR2793691B1 (fr) 1999-05-21 1999-05-21 Utilisation d'anticorps reconnaissant le recepteur de l'interleukine-2 dans la prevention et/ou le traitement des infections par les virus du sida
PCT/FR2000/001399 WO2000071159A1 (fr) 1999-05-21 2000-05-22 Utilisation d'anticorps reconnaissant le recepteur de l'interleukine-2 dans la prevention et/ou le traitement des infections par les virus du sida.

Publications (1)

Publication Number Publication Date
AP2001002354A0 true AP2001002354A0 (en) 2001-12-31

Family

ID=9545913

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/2001/002354A AP2001002354A0 (en) 1999-05-21 2000-05-22 Use of antibodies recognizing the interleukin-2 receptor in the prevention and /or treatment of infections by the AIDS viruses.

Country Status (8)

Country Link
EP (1) EP1178827A1 (fr)
AP (1) AP2001002354A0 (fr)
AU (1) AU4930300A (fr)
CA (1) CA2373991A1 (fr)
EA (1) EA200101228A1 (fr)
FR (1) FR2793691B1 (fr)
OA (1) OA12311A (fr)
WO (1) WO2000071159A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05005160A (es) 2002-11-15 2005-07-22 Genmab As Anticuerpos monoclonales humanos contra la cd25.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3815472A1 (de) * 1988-05-06 1989-11-16 Centre Regional De Transfusion Monoklonaler antikoerper und seine verwendung
JPH024800A (ja) * 1988-06-24 1990-01-09 Ube Ind Ltd インターロイキン２レセプターの除去モジュールおよびそれを用いたインターロイキン２レセプターの除去方法
HUT60768A (en) * 1990-03-16 1992-10-28 Sandoz Ag Process for producing cd25 fixing molecules
JPH05244982A (ja) * 1991-12-06 1993-09-24 Sumitomo Chem Co Ltd 擬人化ｂ−ｂ１０

Also Published As

Publication number Publication date
OA12311A (fr) 2006-05-12
EP1178827A1 (fr) 2002-02-13
CA2373991A1 (fr) 2000-11-30
WO2000071159A1 (fr) 2000-11-30
FR2793691A1 (fr) 2000-11-24
AU4930300A (en) 2000-12-12
EA200101228A1 (ru) 2002-08-29
FR2793691B1 (fr) 2003-10-03

Similar Documents

Publication Publication Date Title
ATE418562T1 (de) Ctl epitope des epstein-barr virus
BR0309581A (pt) Derivados de nucleosìdeo para tratamento de infecção por vìrus de hepatite c
EA200000840A1 (ru) Антивирусные производные пиримидина
FR12C0004I1 (fr)
HK1009980A1 (en) Method for selective inactivation of viral replication
PL354976A1 (en) Factor ix/factor ixa antibodies and antibody derivatives
WO2004028454A3 (fr) 1, 3, 5-triazines destinees au traitement de maladies virales
DE60137337D1 (de) Vorbeugende und therapeutsche monoklonale antikörper gegen vacciniavirusantigene
WO2002092006A3 (fr) Composes a base d'acides nucleiques et procedes d'utilisation associes
EP1256348A4 (fr) Remedes contre l'hepatite c
PT1242119E (pt) Combinacoes para o tratamento de infeccoes por virus adn incluindo um diuretico de ansa e um glicosido cardiotonico
WO2007002639A3 (fr) Agents anti-hepacivirus non-nucleoside et utilisations de ceux-ci
DE69738512D1 (de) Epstein-barr virus type b ctl epitopen
ZA991029B (en) Composition and methods for treatment of hiv infections.
WO2001091789A3 (fr) Utilisation de virus herpetiques mutants et d'agents anticancereux dans le traitement du cancer
AP2001002354A0 (en) Use of antibodies recognizing the interleukin-2 receptor in the prevention and /or treatment of infections by the AIDS viruses.
AU3439799A (en) Immunization against and treatment for infection by (h.pylori)
UA90477C2 (ru) Способ лечения гепатита с (варианты)
EP0227604A3 (fr) Emploi d'oligopeptides dans le traitement d'infections virales
ATE253936T1 (de) Glutathion-reduktase zur behandlung und prophylaxe von aids
NZ512850A (en) Treatment of papillomavirus infections
ZA200205470B (en) Virus strains for the oncolytic treatment of cancer.
WO2002067984A3 (fr) Materiaux et methodes permettant de detecter, de prevenir et de traiter une infection retrovirale a vih ou a vif
WO2004006843A3 (fr) Polytherapies a base de l-fmau pour le traitement de l'infection par le virus de l'hepatite b
DK1459748T3 (da) (S,S)-reboxetin til behandling af perifer neuropati